Following the release of the company’s results for the second quarter of fiscal year 2026, several leading analytical platforms upgraded their assessments of the issuer’s shares. Analysts at UBS Group AG revised the price target for Alibaba Health to HKD 4.70 from HKD 3.80, maintaining a neutral rating. The revision was attributed to stronger-than-expected growth in primary market sales in China. Another positive assessment came from Susquehanna International Group, whose analysts raised the target price for Alibaba shares from USD 180.00 to USD 190.00, compared with the current quotation near USD 157.00. Strong demand for Alibaba Group Holdings Ltd.’s artificial intelligence (AI) and cloud technology solutions was highlighted, confirming growth in these business segments.
The company’s financial results were published on November 25. Revenue amounted to CNY 247.8 billion, exceeding both the figure for the same period last year (CNY 236.5 billion) and the previous quarter’s result of CNY 247.7 billion. Earnings per share reached CNY 4.36, compared with CNY 15.06 and CNY 14.75, respectively.
Management has so far limited shareholder returns to an extraordinary dividend payment of CNY 1.98 per share on July 10. The dividend yield reached 1.66% annually, which is above the sector average of 0.60%.
Support and resistance levels
Quotes are declining: on the daily chart, the price is moving away from the upper boundary of a local descending channel with dynamic limits at 173.00–145.00.
Technical indicators remain in a stable sell signal. The EMA range on the Alligator indicator is expanding, while the AO histogram in the sell zone is forming new downward bars.
Support levels: 149.80, 130.60.
Resistance levels: 163.70, 182.00.

Trading scenarios and forecast for Alibaba shares
If a reversal occurs and the decline continues, with the price consolidating below the support level of 149.80, short positions may be considered with a target at 130.60 and a stop loss at 155.00. Implementation period: 7 days or more.
If the upward movement continues and the price consolidates above the resistance level of 163.70, long positions may be considered with a target at 182.00. Stop loss — 157.00.
Scenario
| Timeframe | Weekly |
| Recommendation | SELL STOP |
| Entry point | 149.75 |
| Take Profit | 130.60 |
| Stop Loss | 155.00 |
| Key levels | 130.60, 149.80, 163.70, 182.00 |
Alternative scenario
| Recommendation | BUY STOP |
| Entry point | 163.75 |
| Take Profit | 182.00 |
| Stop Loss | 157.00 |
| Key levels | 130.60, 149.80, 163.70, 182.00 |